Aeolus Pharmaceuticals Inc (OTCQB:AOLS)

0.26
Delayed Data
As of Feb 27
 +0.005 / +1.96%
Today’s Change
0.19
Today|||52-Week Range
0.55
+13.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues4.8M7.3M3.9M9.6M
 
 
 
 
 
Depreciation And Amortization5.0K7.0K6.0K0.00
 
 
 
 
 
Operating ExpensesGross Income------9.6M
 
 
General Expenses8.7M9.7M6.6M9.7M
 
 
 
 
 
Research And Development5.1M6.5M3.4M7.0M
 
 
 
 
 
Total Operating Expenses8.7M9.7M6.6M9.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.9M-2.4M-2.7M-80.0K
 
 
 
 
 
Extraordinary Credit3.9M4.1M0.000.00
 
 
 
Extraordinary Charge0.000.00-510.0K0.00
 
 
Interest Expense On Debt21.0K0.000.000.00
 
 
Other Expenses335.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income299.0K1.7M-3.2M-80.0K
 
 
 
 
 
Net Income299.0K1.7M-3.2M-80.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS59.5M61.6M106.6M134.7M
 
 
 
 
 
Shares To Calculate EPS Diluted82.3M72.7M106.6M134.7M
 
 
 
 
 
 
Earnings Per ShareEPS--$0.02-$0.03$0.00
 
 
 
EPS Diluted$0.00$0.02-$0.03-$0.00
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account